+1,057.4%
MRNA vs IOVA
-23.7%
+1,081.0%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | IOVA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | -2.7% | -0.9% | -3.0% |
| 7D | -20.0% | -7.6% | -12.4% | -18.5% |
| 30D | -1.3% | -44.6% | +43.3% | +9.9% |
| 3M | +240.0% | +8.2% | +231.8% | +224.4% |
| 6M | +339.0% | +118.8% | +220.1% | +252.2% |
| YTD | +630.0% | +176.6% | +453.4% | +443.6% |
| 1Y | +769.1% | +205.7% | +563.4% | +532.0% |
| 3Y | +181.2% | +71.6% | +109.6% | +98.8% |
| 5Y | -8.1% | -61.6% | +53.5% | -24.0% |
| All | +1,057.4% | -23.7% | +1,081.0% | +639.8% |
Cumulative growth
Daily Returns
Daily percentage return beside IOVA.
Daily Out/Under-Performance
Portfolio return minus IOVA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IOVA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded IOVA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling